Dr. Stefanie Loeser
About Dr. Stefanie Loeser
Dr. Stefanie Loeser is the Senior Medical Manager Oncology Pipeline & Upper GI at Bristol Myers Squibb in München, Bayern, Deutschland, with extensive experience in cancer biology and immunology research.
Company
Dr. Stefanie Loeser is currently employed at Bristol Myers Squibb in München, Bayern, Deutschland. Her role as Senior Medical Manager Oncology Pipeline & Upper Gi involves overseeing various aspects of oncology pipeline development. Bristol Myers Squibb is known for its significant contributions in the fields of oncology and biopharmaceuticals.
Title
Dr. Stefanie Loeser holds the title of Senior Medical Manager Oncology Pipeline & Upper Gi at Bristol Myers Squibb. In this capacity, she is responsible for managing medical activities related to upper gastrointestinal cancers and the oncology pipeline, ensuring effective communication and coordination within the medical management team.
Professional Experience
Dr. Stefanie Loeser has accumulated extensive experience in the medical and oncology fields. She previously served as Disease Area Specialist Oncology at Bristol Myers Squibb from 2016 to 2021. From 2014 to 2016, she was a Scientific Advisor Immuno-Oncology at the same company. Her earlier roles include Medical Advisor Oncology at Novartis, Medical Information and Communication Manager Oncology/Haematology at Amgen GmbH, and Postdoc at Genentech. Additionally, Dr. Loeser has conducted research as a Research Fellow and PhD student at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and as a Diploma student at Max Planck Institute for Neurobiology.
Education and Expertise
Dr. Stefanie Loeser holds a PhD in Molecular Biology from Universität Wien, obtained between 2003 and 2007. She completed her undergraduate studies in Biology, earning a Diploma from Ludwig-Maximilians-Universität München. Her educational background provides her with specialized knowledge in cancer biology and immunology. Dr. Loeser is proficient in evaluating biologics and low molecular weight compounds in preclinical cancer models, as well as in the statistical analysis of clinical data sets.
Background in Oncology Research
With over 10 years of experience in cancer biology and immunology research, Dr. Stefanie Loeser has worked in various top-tier industry and academic institutions. She has led Medical Pre-/-Post launch activities for the first PD-1 compound and the first Immuno-Oncology combination therapy in Austria, demonstrating her expertise in oncological product launches. Her role extends to critical evaluation of medical and scientific information, focusing on customer training and interdisciplinary collaboration.